Folgen
Adrienne C. Lahti, M.D.
Adrienne C. Lahti, M.D.
Bestätigte E-Mail-Adresse bei uab.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
AC Lahti, B Koffel, D LaPorte, CA Tamminga
Neuropsychopharmacology 13 (1), 9-19, 1995
11621995
Effects of ketamine in normal and schizophrenic volunteers
AC Lahti, MA Weiler, BAT Michaelidis, A Parwani, CA Tamminga
Neuropsychopharmacology 25 (4), 455-467, 2001
8082001
Decisional capacity for informed consent in schizophrenia research
WT Carpenter, JM Gold, AC Lahti, CA Queern, RR Conley, JJ Bartko, ...
Archives of general Psychiatry 57 (6), 533-538, 2000
6332000
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network
S Gulsuner, T Walsh, AC Watts, MK Lee, AM Thornton, S Casadei, ...
Cell 154 (3), 518-529, 2013
5932013
Ketamine activates psychosis and alters limbic blood flow in schizophrenia
AC Lahti, HH Holcomb, DR Medoff, CA Tamminga
Neuroreport 6 (6), 869-872, 1995
5441995
Probing the human hippocampus using rCBF: contrasts in schizophrenia
DR Medoff, HH Holcomb, AC Lahti, CA Tamminga
Hippocampus 11 (5), 543-550, 2001
2982001
Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine
LE Hong, A Summerfelt, RW Buchanan, P O'donnell, GK Thaker, ...
Neuropsychopharmacology 35 (3), 632-640, 2010
2592010
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
SM Robert, SC Buckingham, SL Campbell, S Robel, KT Holt, ...
Science translational medicine 7 (289), 289ra86-289ra86, 2015
2332015
Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature
B Birur, NV Kraguljac, RC Shelton, AC Lahti
NPJ schizophrenia 3 (1), 15, 2017
2272017
Neurometabolites in schizophrenia and bipolar disorder—a systematic review and meta-analysis
NV Kraguljac, M Reid, D White, R Jones, J den Hollander, D Lowman, ...
Psychiatry Research: Neuroimaging 203 (2-3), 111-125, 2012
2222012
Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia
NV Kraguljac, DM White, MA Reid, AC Lahti
JAMA psychiatry 70 (12), 1294-1302, 2013
2052013
Sequential regional cerebral blood flow brain scans using PET with H215O demonstrate ketamine actions in CNS dynamically
HH Holcomb, AC Lahti, DR Medoff, M Weiler, CA Tamminga
Neuropsychopharmacology 25 (2), 165-172, 2001
1792001
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia
AC Lahti, MA Weiler, HH Holcomb, CA Tamminga, WT Carpenter, ...
Neuropsychopharmacology 31 (1), 221-230, 2006
1752006
Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers
JF Artaloytia, C Arango, A Lahti, J Sanz, A Pascual, P Cubero, D Prieto, ...
American Journal of Psychiatry 163 (3), 488-493, 2006
1722006
Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia
JA Hadley, R Nenert, NV Kraguljac, MS Bolding, DM White, FM Skidmore, ...
Neuropsychopharmacology 39 (4), 1020-1030, 2014
1622014
Functional effects of antipsychotic drugs: comparing clozapine with haloperidol
AC Lahti, HH Holcomb, MA Weiler, DR Medoff, CA Tamminga
Biological psychiatry 53 (7), 601-608, 2003
1552003
Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia
MA Reid, LE Stoeckel, DM White, KB Avsar, MS Bolding, NS Akella, ...
Biological psychiatry 68 (7), 625-633, 2010
1432010
Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates
LE Libero, TP DeRamus, AC Lahti, G Deshpande, RK Kana
Cortex 66, 46-59, 2015
1422015
How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference
KL Cropsey, LR Trent, CB Clark, EN Stevens, AC Lahti, PS Hendricks
Nicotine & Tobacco Research 16 (10), 1348-1355, 2014
1412014
Antipsychotic properties of the partial dopamine agonist (−)-3-(3-hydroxyphenyl)-Nn-propylpiperidine (preclamol) in schizophrenia
AC Lahti, MA Weiler, PK Corey, RA Lahti, A Carlsson, CA Tamminga
Biological psychiatry 43 (1), 2-11, 1998
1351998
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20